The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Condition:   Schizophrenia Intervention:   Drug: Lurasidone Sponsor:   Sumitomo Pharmaceutical (Suzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
Conditions:   Nausea;   Vomiting;   Head and Neck Squamous Cell Carcinoma;   Radiotherapy Side Effect Intervention:   Drug: Olanzapine Sponsor:   Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials